Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Infinvitality is a biotechnology company focused on the development and commercialization of longevity-enhancing supplements and therapeutic interventions. The company specializes in cellular health, specifically targeting the restoration of nicotinamide adenine dinucleotide (NAD+) levels and the activation of sirtuins to combat age-related physiological decline. Their product portfolio includes high-purity NMN (Nicotinamide Mononucleotide) formulations and other synergistic compounds designed to improve metabolic function and cognitive health. Infinvitality bridges the gap between advanced longevity research and consumer-accessible health solutions through rigorous quality control and evidence-based product development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Infinvitality Company.